Veracyte Inc. is a genomic diagnostics company that specializes in developing tests aimed at improving patient outcomes in the diagnosis of thyroid cancer, lung cancer, and idiopathic pulmonary fibrosis. With a focus on genomic technology, the company aims to provide physicians with accurate and reliable information to make informed treatment decisions.